Literature DB >> 23353000

Neonatal immune challenge exacerbates seizure-induced hippocampus-dependent memory impairment in adult rats.

Ping Yin1, Zhen Li, Ying-Yan Wang, Na-Na Qiao, Shan-Ying Huang, Ruo-Peng Sun, Ji-Wen Wang.   

Abstract

Our aim was to examine whether neonatal lipopolysaccharide (LPS) exposure is associated with changes in microglia and whether these alternations could influence later seizure-induced neurobehavioral outcomes. Male pups were first injected intraperitoneally with either LPS or saline on postnatal day 3 (P3) and postnatal day 5 (P5). Immunohistochemical analysis showed that LPS-treated animals exhibited increased microglia activation that persisted into adolescence. At P45, seizures were induced in rats by intraperitoneal injection of kainic acid (KA). Rats treated with LPS neonatally showed significantly greater proinflammatory responses and performed significantly worse in the Y-maze, Morris water maze, and inhibitory avoidance tasks after KA insult. Treatment with minocycline at the time of neonatal LPS exposure to block LPS-induced microglia alternation attenuated the exaggerated neuroinflammatory responses and alleviated memory impairment associated with the KA insult. Our findings suggest that neonatal immune activation can predispose the brain to exacerbated behavioral deficits following seizures in adulthood, possibly by priming microglia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353000     DOI: 10.1016/j.yebeh.2012.12.015

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  9 in total

Review 1.  Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

Authors:  Elissa J Donzis; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2014-08-21       Impact factor: 2.877

2.  Minocycline causes widespread cell death and increases microglial labeling in the neonatal mouse brain.

Authors:  J Alex Strahan; William H Walker; Taylor R Montgomery; Nancy G Forger
Journal:  Dev Neurobiol       Date:  2016-10-14       Impact factor: 3.964

3.  Association Between IL-6 and Seizure Recurrence in Patients with the First Post-Ischemic Stroke Seizure.

Authors:  Qi Jia; Fan Jiang; Daliang Ma; Jun Li; Fan Wang; Zhiqiang Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-08-11       Impact factor: 2.570

4.  Candesartan ameliorates impaired fear extinction induced by innate immune activation.

Authors:  María M Quiñones; Lizette Maldonado; Bethzaly Velazquez; James T Porter
Journal:  Brain Behav Immun       Date:  2015-10-28       Impact factor: 7.217

Review 5.  Systemic inflammation and microglial activation: systematic review of animal experiments.

Authors:  Inge C M Hoogland; Carin Houbolt; David J van Westerloo; Willem A van Gool; Diederik van de Beek
Journal:  J Neuroinflammation       Date:  2015-06-06       Impact factor: 8.322

6.  Early changes in pro-inflammatory cytokine levels in neonates with encephalopathy are associated with remote epilepsy.

Authors:  Adam L Numis; Audrey Foster-Barber; Xutao Deng; Elizabeth E Rogers; A James Barkovich; Donna M Ferriero; Hannah C Glass
Journal:  Pediatr Res       Date:  2019-06-24       Impact factor: 3.756

7.  Alteration of the brain methylation landscape following postnatal inflammatory injury in rat pups.

Authors:  Wyston C Pierre; Lisa-Marie Legault; Irene Londono; Serge McGraw; Gregory A Lodygensky
Journal:  FASEB J       Date:  2019-11-22       Impact factor: 5.191

8.  Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats.

Authors:  Bombi Lee; Bongjun Sur; Jinhee Park; Sung-Hun Kim; Sunoh Kwon; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  Biomol Ther (Seoul)       Date:  2013-09-30       Impact factor: 4.634

Review 9.  Neonatal Seizures and Purinergic Signalling.

Authors:  Aida Menéndez Méndez; Jonathon Smith; Tobias Engel
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.